Decibel Bio
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- $12M
Investors
- 4
About Decibel Bio
Decibel Bio focuses on developing a unique platform for plant biology, allowing for tailored crop traits through methods like foliar sprays.Decibel Bio specializes in an innovative platform that allows for the programming of plant biology, making it possible to provide crops with tailored traits through methods such as foliar sprays or seed treatments. This approach enables growers to enhance crop characteristics like yield, disease resistance, nutrient uptake, and stress tolerance, effectively adapting to the unique challenges posed by changing environmental conditions and market demands. The core product offerings revolve around their patented epigenome-driven foundational models, which can predict agronomic outcomes more accurately than traditional crop models. The primary customers for these services are seed breeders, agricultural companies, and growers seeking to improve crop performance.Decibel Bio's revenue model is structured around partnerships and collaborations with seed breeders and agricultural companies, facilitating the implementation of their epigenetic programming technology. Transactions typically occur through direct agreements where clients engage Decibel for the application of their innovative crop trait solutions, thereby enhancing the agricultural yield and resilience of their products. The company generates revenue through these collaborative arrangements, enabling seed breeders to access faster, more efficient trait development processes. Specific pricing plans and revenue structures are tailored to the nature of the contracts and the scope of services provided, which may vary based on client needs and project size. The company aims to launch new products designed to enhance crop resilience and yield in the near future, with specific timelines yet to be disclosed. Plans for expansion target emerging agricultural markets in Europe and Asia by 2026, where the need for innovative agricultural solutions is growing.
Who invested in Decibel Bio
4 investors across 1 round
See all investors in Decibel Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 5, 2025
Amount
$12M
Investors
Questions about Decibel Bio
Who invested in Decibel Bio?
Decibel Bio has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Decibel Bio raised?
Decibel Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Decibel Bio last raise money?
Decibel Bio's most recent round on record is a Series A, in Mar 2025.
What does Decibel Bio do?
Decibel Bio focuses on developing a unique platform for plant biology, allowing for tailored crop traits through methods like foliar sprays.
Where is Decibel Bio headquartered?
Decibel Bio is headquartered in Berkeley, US.
Which VCs invest in companies like Decibel Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Decibel Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Decibel Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.